PREVIOUS
✖
Paxlovid antiviral covid pill
April 25 , 2022
819 days
591
0
- WHO made a strong recommendation for nirmatrelvir and ritonavir, sold under the name Paxlovid, for mild and moderate COVID-19 patients at the highest risk of hospital admission.
- WHO calls it the best therapeutic choice for high-risk patients to date.
Leave a Reply
Your Comment is awaiting moderation.